| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 20 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 20 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 20 |
| 3 | TRASTUZUMAB | 18 |
| 4 | DOXORUBICIN | 15 |
| 5 | DOCETAXEL | 11 |
| 6 | DOCETAXEL ANHYDROUS | 11 |
| 7 | BUSULFAN | 10 |
| 8 | CARBOPLATIN | 10 |
| 9 | CISPLATIN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOPOTECAN HYDROCHLORIDE | 8 | 0.0033 |
| 1 | THIOTEPA | 10 | 0.0010 |
| 2 | BUSULFAN | 10 | 0.0006 |
| 3 | ADO-TRASTUZUMAB EMTANSINE | 5 | 0.0006 |
| 4 | MELPHALAN HYDROCHLORIDE | 10 | 0.0004 |
| 5 | TOPOTECAN | 2 | 0.0003 |
| 6 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 3 | 0.0003 |
| 7 | VINCRISTINE SULFATE | 8 | 0.0003 |
| 8 | TRASTUZUMAB | 18 | 0.0003 |
| 9 | GLUCAGON | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 20 | 0.0003 |
| 1 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 2 | Topoisomerase Inhibitor [EPC] | 10 | 0.0001 |
| 3 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 22 | 0.0001 |
| 5 | Alkaloid [EPC] | 2 | 0.0001 |
| 6 | Microtubule Inhibitor [EPC] | 11 | 0.0001 |
| 7 | Anticholinergic [EPC] | 1 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 10 | 0.0000 |